SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2016-08-09
Tx date 2016-08-04
$VVS
Avapecia Life Sciences Corp.
Neweduk, Peter Micheal
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$200.00
+4,000 vol
$0.05 each
2,553,250
Filed 2016-01-25
Tx date 2016-01-15
$VVS
Avapecia Life Sciences Corp.
Tsui, Norman
4 - Director of Issuer
Holder: Norman Tsui ITF Brianna Tsui (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
860,000
Filed 2016-01-25
Tx date 2016-01-15
$VVS
Avapecia Life Sciences Corp.
Tsui, Norman
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
11,640,000
Filed 2016-01-25
Tx date 2016-01-15
$VVS
Avapecia Life Sciences Corp.
Tsui, Norman
4 - Director of Issuer
Holder: Norman Tsui ITF Ethan Tsui (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
860,000
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Holder: Percy Gar Kay Cheung (Control or Direction)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+67,500 vol
67,500
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+652,500 vol
2,152,500
Filed 2016-01-05
Tx date 2014-05-16
$VVS
Avapecia Life Sciences Corp.
Huang, Lotien Richard
3 - 10% Security Holder of Issuer
Holder: Cytostream Life Sciences Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Huang, Lotien Richard
3 - 10% Security Holder of Issuer
Holder: Cytostream Life Sciences Inc. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+72,000 vol
72,000
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Neweduk, Peter Micheal
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Lynnett Darrell (Control or Direction)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+22,500 vol
86,500
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Neweduk, Peter Micheal
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Lynnett Darrell (Control or Direction)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+22,500 vol
109,000
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Neweduk, Peter Micheal
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+533,250 vol
2,549,250
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Tam, Alan Shui Yan
3 - 10% Security Holder of Issuer
Holder: Cyto IQ Biomedical Corp. (Control or Direction)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+9,947,543 vol
25,847,543
Filed 2016-01-05
Tx date 2014-05-30
$VVS
Avapecia Life Sciences Corp.
Tam, Alan Shui Yan
3 - 10% Security Holder of Issuer
Holder: Dawn Tam (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Tam, Alan Shui Yan
3 - 10% Security Holder of Issuer
Holder: Dawn Tam (Control or Direction)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+720,000 vol
720,000
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Tam, Alan Shui Yan
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+3,074,999 vol
5,324,999
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Nerland, Dennis Leroy
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+686,250 vol
1,786,250
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
CHANG, MICHELE KAR MAN
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+45,000 vol
182,000
Filed 2016-01-05
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
CHANG, MICHELE KAR MAN
4 - Director of Issuer
Holder: Tony H.Y. Leung (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+45,000 vol
182,000
Filed 2016-01-05
Tx date 2014-11-10
$VVS
Avapecia Life Sciences Corp.
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Holder: Percy Gar Kay Cheung (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-04
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Fuller, Jason Peter
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+616,500 vol
1,116,500
Filed 2016-01-04
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Huang, Lotien Richard
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+18,407,545 vol
39,107,545
Filed 2016-01-04
Tx date 2015-12-21
$VVS
Avapecia Life Sciences Corp.
Fuller, Jason Peter
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Fuller Family Trust (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+247,500 vol
247,500
Filed 2016-01-04
Tx date 2014-01-10
$VVS
Avapecia Life Sciences Corp.
Fuller, Jason Peter
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Fuller Family Trust (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report